Jason Gardner

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Cindy Driscoll, Attorney-in-Fact for Jason Gardner
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jason Gardner

Form 4 holding Title: President and Chief Executive Officer, Director

Magenta Therapeutics, Inc.

Security class
Common Stock
Shares / value
359,092
Estimated value
$4,309,104
Report date
30 Nov 2022
Price
$12.00
Ownership
By P.S. Gardner Irrevocable Trust
Form 4 holding Title: President and Chief Executive Officer, Director

Magenta Therapeutics, Inc.

Security class
Common Stock
Shares / value
292,990
Estimated value
$3,515,880
Report date
30 Nov 2022
Price
$12.00
Ownership
By J.P. Gardner Irrevocable Trust
Form 4 holding Title: President and Chief Executive Officer, Director

Magenta Therapeutics, Inc.

Security class
Common Stock
Shares / value
292,872
Estimated value
$3,514,464
Report date
30 Nov 2022
Price
$12.00
Ownership
Direct

Insider Reports Filed by Jason Gardner

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .